Abstract:Background: early death in patients with non-small cell lung cancer remains an unresolved issue. Therefore, it is necessary to identify the risk factors for early death in non-small cell lung cancer patients. Purpose: The purpose of this study was to identify associated risk factors and develop a predictive nomogram for the early death of non-small cell lung cancer patients. Research method: We enrolled 51529 patients in SEER Database who were 60 years or older, diagnosed with primary non-small cell lung cancer, from 2010 to 2016. All patients were randomly divided into training and testing sets at 7:3. Multivariate COX proportional hazard regression was used to identify independent risk variables for early death. Use K-M survival curve to compare different molecular subtypes, metastatic sites, and treatment methods on the survival status of lung cancer patients. A predictive nomogram was developed to predict the 1-year overall survival (OS) and then validated by calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). RESULTS: Eight independent variables, including race, sex, age, tumor size, AJCC M, molecular subtype, metastatic site and treatment were recognized by using multivariate COX proportional hazard regression model for identifying independent risk variables of early death about non-small cell lung cancer patients. By comprising these variables, a predictive nomogram was constructed in the training set cohort. In the nomogram of 1-year overall survival, the areas under the ROC curves were 0.781 (95% CI: 0.771–0.804) and for the training dataset as well as (95% CI: 0.761–0.821) for the validation dataset. Then, the consistency between the predicted and actual overall survival was confirmed by the calibration curves. Additionally, the results of the DCA indicated that the predictive model had a favorable clinical applicability. Conclusion: In the early stages of non-small cell lung cancer (NSCLC), different molecular subtypes, metastatic sites, and treatment methods can significantly affect the survival rate of patients. The nomogram model developed in this study provides an insightful and applicable tool for predicting the risk of early mortality in NSCLC patients. It can help clinicians identify patients at high risk of early death and tailor their treatment plans accordingly, potentially improving patient outcomes.

Data Decision and Drug Therapy Based on Non-Small Cell Lung Cancer in a Big Data Medical System in Developing Countries

Analysis of Coronary Heart Disease Drug Therapy Based on Clinical Data Mining

A Study on Data-Driven Novel Cancer Staging Methods

Medical decision support system for cancer treatment in precision medicine in developing countries

Big Medical Data Decision-Making Intelligent System Exploiting Fuzzy Inference Logic for Prostate Cancer in Developing Countries

Efficacy prediction based on attribute and multi-source data collaborative for auxiliary medical system in developing countries

Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision making

AI-Driven Synthetic Biology for Non-Small Cell Lung Cancer Drug Effectiveness-Cost Analysis in Intelligent Assisted Medical Systems

Statistical modeling to unravel multiple predictors of the choice of chemotherapy for non-small cell lung cancer

Statistical Modeling to Unravel Multiple Predictors of the Choice of Chemotherapy for Non-Small Cell Lung Cancer.

Artificial Intelligence-Assisted Decision Making for Prognosis and Drug Efficacy Prediction in Lung Cancer Patients: a Narrative Review

A Linked Data Based Decision Support System for Cancer Treatment

An Economic Decision-Making Model for Drugs Using Big Data and Convolution Neural Network in Healthcare

Design and Application of Clinical Big Data Management System for Oncology

Intelligent Analysis for Improving The Clinical Pathway of Lung Cancer

Data – Knowledge driven machine learning model for cancer pain medication decisions

A Staging Auxiliary Diagnosis Model for Nonsmall Cell Lung Cancer Based on the Intelligent Medical System

Personalized Anti-Tumor Drug Efficacy Prediction Based on Clinical Data

Effect and Prediction of Molecular Subtype, Metastatic Site and Treatment for Early Death in Non-Small Cell Lung Cancer: A SEER-based Study

Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study

Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning